Trump's 200% tariff plan may be a bitter pill for US consumers; Dr Reddy's warns of costlier medicines

Source Summary

India Business News: The US is putting generic medicines on the tariff map, with duties set to rise to as much as 200% in the coming years to boost local manufacturing. Bu.